Information:
Fel:
ID
22307
Beskrivning
ALTROPANE® SPECT Imaging in Patients With Parkinson Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00397228
Länk
https://clinicaltrials.gov/show/NCT00397228
Nyckelord
Versioner (1)
- 2017-05-29 2017-05-29 -
Uppladdad den
29 maj 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson Disease NCT00397228
Eligibility Parkinson Disease NCT00397228
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson Disease NCT00397228
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age | Parkinson Disease
Item
the participant is 30 years or older at time of pd diagnosis.
boolean
C0001779 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0030567 (UMLS CUI [2])
Informed Consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
Parkinson Disease disease length
Item
participants have a clinical diagnosis of idiopathic parkinson's disease of < 7 years.
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Hoehn and Yahr Stage
Item
hoehn and yahr stages i-iii.
boolean
C3639483 (UMLS CUI [1])
Drug screen negative
Item
negative drug screen
boolean
C0919819 (UMLS CUI [1])
Atypical Parkinson Disease | Parkinson Disease Drug-induced
Item
the participant has atypical or drug-induced parkinson's disease.
boolean
C1868596 (UMLS CUI [1])
C0030567 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
C0030567 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
Dementia
Item
the participant has dementia.
boolean
C0497327 (UMLS CUI [1])
Laboratory Results Clinical Significance | Illness Unstable | Mental disorders Unstable
Item
the participant has a clinically significant clinical laboratory value and/or clinically significant unstable medical or psychiatric illness.
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0004936 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C2826293 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0004936 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
Bupropion | Methylphenidate | Reserpine | Methyldopa | Amphetamines
Item
treatment within the six months prior to screening with bupropion, methylphenidate, reserpine, alpha methyldopa, or amphetamine.
boolean
C0085208 (UMLS CUI [1])
C0025810 (UMLS CUI [2])
C0035179 (UMLS CUI [3])
C0025741 (UMLS CUI [4])
C0002667 (UMLS CUI [5])
C0025810 (UMLS CUI [2])
C0035179 (UMLS CUI [3])
C0025741 (UMLS CUI [4])
C0002667 (UMLS CUI [5])
Substance Use Disorders | Narcotic Abuse
Item
the participant has a history of alcohol, narcotic, or any other drug abuse within the past 2 years.
boolean
C0038586 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
C0524661 (UMLS CUI [2])
Investigational New Drugs
Item
the participant has received an investigational drug within 60 days of screening visit.
boolean
C0013230 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])